Cancer in Systemic Sclerosis: Analysis of Antibodies Against Components of the Th/To Complex.
Christopher A MecoliBrittany L AdlerQingyuan YangLaura K HummersAntony RosenLivia A Casciola-RosenChristopher A MecoliPublished in: Arthritis & rheumatology (Hoboken, N.J.) (2020)
SSc patients who produce autoantibodies to components of the Th/To complex have a clinical phenotype characterized by limited cutaneous disease and pulmonary involvement. Our findings show that the presence of any Th/To autoantibody may have a protective effect against contemporaneous cancer.